Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 2
1972 1
1973 6
1974 8
1975 12
1976 8
1977 5
1978 8
1979 7
1980 16
1981 10
1982 13
1983 15
1984 11
1985 12
1986 19
1987 23
1988 12
1989 16
1990 9
1991 21
1992 18
1993 28
1994 34
1995 32
1996 28
1997 48
1998 41
1999 47
2000 35
2001 33
2002 31
2003 36
2004 39
2005 38
2006 44
2007 38
2008 41
2009 32
2010 47
2011 37
2012 31
2013 25
2014 32
2015 34
2016 29
2017 33
2018 20
2019 23
2020 22
2021 29
2022 17
2023 15
2024 27
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,231 results

Results by year

Filters applied: . Clear all
Page 1
Mild cognitive impairment.
Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment. Gauthier S, et al. Among authors: winblad b. Lancet. 2006 Apr 15;367(9518):1262-70. doi: 10.1016/S0140-6736(06)68542-5. Lancet. 2006. PMID: 16631882 Review.
Current concepts in mild cognitive impairment.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Petersen RC, et al. Among authors: winblad b. Arch Neurol. 2001 Dec;58(12):1985-92. doi: 10.1001/archneur.58.12.1985. Arch Neurol. 2001. PMID: 11735772 Review.
Alzheimer's disease: clinical trials and drug development.
Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Mangialasche F, et al. Among authors: winblad b. Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8. Lancet Neurol. 2010. PMID: 20610346 Review.
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Winblad B, et al. J Intern Med. 2004 Sep;256(3):240-6. doi: 10.1111/j.1365-2796.2004.01380.x. J Intern Med. 2004. PMID: 15324367 Free article. Review.
Amyloid-lowering treatment in Alzheimer's disease.
Jessen F, Frölich L, Hort J, Winblad B, Fortea J. Jessen F, et al. Among authors: winblad b. Lancet. 2024 Nov 30;404(10468):2161-2162. doi: 10.1016/S0140-6736(24)02510-8. Epub 2024 Nov 14. Lancet. 2024. PMID: 39551061 No abstract available.
Regulatory asymmetry in Alzheimer's disease care.
Fortea J, Boban M, Engelborghs S, Frederiksen KS, Hort J, Kennelly S, Kramberger MG, Mehrabian S, Plantone D, Paquet C, Santana I, Scarmeas N, Solje E, Spiru L, Šutovský S, Vijverberg EGB, Winblad B, Jessen F. Fortea J, et al. Among authors: winblad b. Lancet. 2025 May 24;405(10492):1812-1813. doi: 10.1016/S0140-6736(25)00907-9. Epub 2025 May 14. Lancet. 2025. PMID: 40381642 No abstract available.
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.
Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, Chincarini A, Cagnin A, De Deyn PP, Düzel E, Engelborghs S, Ewers M, Exalto LG, van der Flier WM, Fortea J, Frederiksen KS, Frisoni GB, Frölich L, Garza-Martinez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Kehoe PG, Kennelly SP, Kern S, Klöppel S, Krajčovičová L, Kramberger MG, McGuinness B, Mecocci P, Oberstein TJ, Ousset PJ, Paquet C, Perneczky R, Piazza F, Plantone D, Rainero I, Sacco G, Salmon E, Santana I, Scarmeas N, Schneider A, Schott JM, Solje E, Stefanova E, Stögmann E, Strauss M, Sutovsky S, Waldemar G, Winblad B. Jessen F, et al. Among authors: winblad b. J Prev Alzheimers Dis. 2025 Sep;12(8):100259. doi: 10.1016/j.tjpad.2025.100259. Epub 2025 Jul 9. J Prev Alzheimers Dis. 2025. PMID: 40640062 Free PMC article. No abstract available.
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.
Kovacech B, Cullen NC, Novak P, Hanes J, Kontsekova E, Katina S, Parrak V, Fresser M, Vanbrabant J, Feldman HH, Winblad B, Stoops E, Vanmechelen E, Zilka N. Kovacech B, et al. Among authors: winblad b. Alzheimers Res Ther. 2024 Nov 23;16(1):254. doi: 10.1186/s13195-024-01620-7. Alzheimers Res Ther. 2024. PMID: 39580468 Free PMC article. Clinical Trial.
1,231 results